189 related articles for article (PubMed ID: 25446180)
1. cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.
Duggirala A; Kimura TE; Sala-Newby GB; Johnson JL; Wu YJ; Newby AC; Bond M
J Mol Cell Cardiol; 2015 Feb; 79():157-68. PubMed ID: 25446180
[TBL] [Abstract][Full Text] [Related]
2. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
[TBL] [Abstract][Full Text] [Related]
4. Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells.
Smith MC; Hudson CA; Kimura TE; White SJ; Sala-Newby GB; Newby AC; Bond M
Sci Rep; 2017 Jun; 7(1):3681. PubMed ID: 28623279
[TBL] [Abstract][Full Text] [Related]
5. CRE and SRE mediate LPA-induced CCN1 transcription in mouse aortic smooth muscle cells.
Dou Q; Hao F; Sun L; Xu X; Cui MZ
Can J Physiol Pharmacol; 2017 Mar; 95(3):275-280. PubMed ID: 28157379
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
Nguyen GH; French R; Radhakrishna H
Cell Signal; 2004 Oct; 16(10):1141-51. PubMed ID: 15240009
[TBL] [Abstract][Full Text] [Related]
7. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase 14 is a novel negative regulatory switch for the vascular smooth muscle cell contractile gene program.
Long X; Cowan SL; Miano JM
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):378-86. PubMed ID: 23175675
[TBL] [Abstract][Full Text] [Related]
9. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.
Zhao X; Ding EY; Yu OM; Xiang SY; Tan-Sah VP; Yung BS; Hedgpeth J; Neubig RR; Lau LF; Brown JH; Miyamoto S
J Mol Cell Cardiol; 2014 Oct; 75():152-61. PubMed ID: 25106095
[TBL] [Abstract][Full Text] [Related]
10. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
[TBL] [Abstract][Full Text] [Related]
11. Elevated cyclic-AMP represses expression of exchange protein activated by cAMP (EPAC1) by inhibiting YAP-TEAD activity and HDAC-mediated histone deacetylation.
Ebrahimighaei R; McNeill MC; Smith SA; Wray JP; Ford KL; Newby AC; Bond M
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1634-1649. PubMed ID: 31255721
[TBL] [Abstract][Full Text] [Related]
12. Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD.
McNeill MC; Wray J; Sala-Newby GB; Hindmarch CCT; Smith SA; Ebrahimighaei R; Newby AC; Bond M
Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118691. PubMed ID: 32119877
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization.
Mack CP; Somlyo AV; Hautmann M; Somlyo AP; Owens GK
J Biol Chem; 2001 Jan; 276(1):341-7. PubMed ID: 11035001
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.
Han JS; Macarak E; Rosenbloom J; Chung KC; Chaqour B
Eur J Biochem; 2003 Aug; 270(16):3408-21. PubMed ID: 12899698
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells.
Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321
[TBL] [Abstract][Full Text] [Related]
16. Rnd3/RhoE expression is regulated by G-actin through MKL1-SRF signaling pathway.
Piquet L; Robbe T; Neaud V; Basbous S; Rosciglione S; Saltel F; Moreau V
Exp Cell Res; 2018 Sep; 370(2):227-236. PubMed ID: 29940177
[TBL] [Abstract][Full Text] [Related]
17. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
18. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
19. PKA and Epac synergistically inhibit smooth muscle cell proliferation.
Hewer RC; Sala-Newby GB; Wu YJ; Newby AC; Bond M
J Mol Cell Cardiol; 2011 Jan; 50(1):87-98. PubMed ID: 20971121
[TBL] [Abstract][Full Text] [Related]
20. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase.
Hanna M; Liu H; Amir J; Sun Y; Morris SW; Siddiqui MA; Lau LF; Chaqour B
J Biol Chem; 2009 Aug; 284(34):23125-36. PubMed ID: 19542562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
